OpenURL Connection Search

Select item for more details and to access through your institution.

Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Published in:
Journal of Medical Virology, 2013, v. 85, n. 6, p. 996, doi. 10.1002/jmv.23567
By:
- Salpini, R.;
- Alteri, C.;
- Cento, V.;
- Pollicita, M.;
- Micheli, V.;
- Gubertini, G.;
- De Sanctis, G.M.;
- Visca, M.;
- Romano, S.;
- Sarrecchia, C.;
- Andreoni, M.;
- Angelico, M.;
- Parruti, G.;
- Svicher, V.;
- Perno, C.F.
Publication type:
Article
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.
Published in:
Infection, 2014, v. 42, n. 1, p. 61, doi. 10.1007/s15010-013-0510-3
By:
- Svicher, V.;
- Alteri, C.;
- Montano, M.;
- Nori, A.;
- D'Arrigo, R.;
- Andreoni, M.;
- Angarano, G.;
- Antinori, A.;
- Antonelli, G.;
- Allice, T.;
- Bagnarelli, P.;
- Baldanti, F.;
- Bertoli, A.;
- Borderi, M.;
- Boeri, E.;
- Bon, I.;
- Bruzzone, B.;
- Barresi, R.;
- Calderisi, S.;
- Callegaro, A.
Publication type:
Article
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.
Published in:
2011
By:
- Sarrecchia, C.;
- Svicher, V.;
- Volpi, A.;
- Salpini, R.;
- Ceccarelli, L.;
- Sordillo, P.;
- Bertoli, A.;
- Perno, C.;
- Andreoni, M.
Publication type:
Report
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase of CD4+ cell count, despite virological failure.
Published in:
2008
By:
- Svicher V;
- Aquaro S;
- D'Arrigo R;
- Artese A;
- Dimonte S;
- Alcaro S;
- Santoro MM;
- Di Perri G;
- Lo Caputo S;
- Bellagamba R;
- Zaccarelli M;
- Visco-Comandini U;
- Antinori A;
- Narciso P;
- Ceccherini-Silberstein F;
- Perno C
Publication type:
Journal Article
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.
Published in:
2009
By:
- Alteri C;
- Svicher V;
- Gori C;
- D'Arrigo R;
- Ciccozzi M;
- Ceccherini-Silberstein F;
- Selleri M;
- Bardacci SA;
- Giuliani M;
- Elia P;
- Scognamiglio P;
- Balzano R;
- Orchi N;
- Girardi E;
- Perno CF;
- SENDIH Study Group;
- Alteri, Claudia;
- Svicher, Valentina;
- Gori, Caterina;
- D'Arrigo, Roberta
Publication type:
journal article
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.
Published in:
2017
By:
- Cerva, C.;
- Maffongelli, G.;
- Svicher, V.;
- Salpini, R.;
- Colagrossi, L.;
- Battisti, A.;
- Mariotti, B.;
- Cerretti, R.;
- Cudillo, L.;
- Sarmati, L.
Publication type:
journal article
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1865, doi. 10.1093/jac/dkv029
By:
- Armenia, D.;
- Fabeni, L.;
- Alteri, C.;
- Pinto, D. Di;
- Carlo, D. Di;
- Bertoli, A.;
- Gori, C.;
- Carta, S.;
- Fedele, V.;
- Forbici, F.;
- D'Arrigo, R.;
- Svicher, V.;
- Berno, G.;
- Pizzi, D.;
- Nicastri, E.;
- Sarmati, L.;
- Pinnetti, C.;
- Ammassari, A.;
- D'Offizi, G.;
- Latini, A.
Publication type:
Article

Found: 7

Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.

Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase of CD4+ cell count, despite virological failure.

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.